OBALON THERAPEUTICS INC 4
4 · OBALON THERAPEUTICS INC · Filed Nov 14, 2016
Insider Transaction Report
Form 4
Brister Mark
VP of Research and Development
Transactions
- Award
Stock Option (right to buy)
2016-11-09+90,000→ 90,000 totalExercise: $8.74Exp: 2026-11-09→ Common Stock (90,000 underlying)
Footnotes (1)
- [F1]The option vests as to 2.0833% of the total shares monthly, commencing on December 9, 2016, with 100% of the total shares vested on November 9, 2020, subject to the reporting person's provision of service to the issuer on each vesting date.